Parliamentary Information Technology Committee

The Ad Council Launches Emerging Media & Technology Committee to Accelerate Impact on America's Most Pressing Social Issues

Retrieved on: 
Tuesday, December 12, 2023
Metaverse, Generative, Ad Council, CES, Love, Synthetic media, Privacy, Van Gogh immersive experience, Parliamentary Information Technology Committee, Pride, Virtual reality, Spatial computing, WebXR, Escape Plan: The Extractors, Marketing, Escape Plan, Committee, FEMA, Council, Mental health, Content, Government, AI, Good, Roblox, Smokey Bear, Pet, Meta, EMT, Decentraland

NEW YORK, Dec. 12, 2023 /PRNewswire/ -- Today, the Ad Council, America's leading nonprofit leveraging the power of communications to inspire action and accelerate change around the most pressing issues in America, proudly unveiled the formation of its Emerging Media & Technology (EMT) Committee. The committee is comprised of industry leaders at the forefront of media innovation and technology and is poised to help the Ad Council continue to activate within the new frontiers of media and marketing – leveraging technologies like Generative AI, Web3/Blockchain, Immersive 3D Spaces, Spatial Computing and more – to reach audiences in new ways.

Key Points: 
  • Founding companies and members of the Ad Council's EMT Committee include:
    Reena Jana, Head of Content & Partnership Enablement, Responsible Innovation, Google
    Chris Neff, Global Head of Emerging Experience & Technology, Anomaly
    "The Ad Council has a long history of uniting innovation and social impact.
  • Today's new Emerging Media & Technology Committee represents a collective commitment to harness the power of emerging media and technology for the greater good," said DJ Perera, Chief Media Officer at the Ad Council.
  • Build Responsibly: Discuss responsible development and ethical considerations to ensure accessibility, inclusivity and user mental wellbeing and privacy in the evolving landscape of emerging media and technology.
  • The Ad Council's EMT Committee aims to be a catalyst for positive change, embodying the spirit of innovation, responsibility and collaboration as the nonprofit leverages the dynamic landscape of emerging media and technology for the betterment of society.

Ramaco Resources Board Member Aurelia Skipwith Giacometto Appointed as Head of Louisiana Department of Environmental Quality

Retrieved on: 
Monday, November 27, 2023
Colossal, Leo Giacometto, Steamboat Institute, Coal, Carbon, Agriculture, National Rifle Association, Natural Resources, Parliamentary Information Technology Committee, Trump, Joint Nature Conservation Committee, International order, State, METC, Environmental quality, Science, SURF, Duck, Alltech, Agricultural science, FWS, Hunting, Aurelia

LEXINGTON, Ky., Nov. 27, 2023 /PRNewswire/ -- Today Ramaco Resources, Inc. (NASDAQ: METC) congratulates board member Aurelia Skipwith Giacometto, who has been appointed as Secretary of the Louisiana Department of Environmental Quality by Governor-elect Jeff Landry.

Key Points: 
  • LEXINGTON, Ky., Nov. 27, 2023 /PRNewswire/ -- Today Ramaco Resources, Inc. (NASDAQ: METC) congratulates board member Aurelia Skipwith Giacometto, who has been appointed as Secretary of the Louisiana Department of Environmental Quality by Governor-elect Jeff Landry.
  • Giacometto previously served as Director of the United States Fish and Wildlife Service (FWS) during the Trump administration.
  • "Aurelia has been an invaluable member of the Ramaco board, who leads our Technology Committee in exploring alternative uses for coal to make advanced carbon products and materials.
  • "Louisiana is unique in its natural resources, which attract many people to the State," said Aurelia Skipwith Giacometto.

Lance F. Drummond Elected Chair of Freddie Mac

Retrieved on: 
Tuesday, November 7, 2023
Dun, Parliamentary Information Technology Committee, Bank, Housing, Operation, Bradstreet, Freddie Mac, Procter & Gamble, Drummond, Operations and technology management, Human resources, Bank of America, FHFA, Kodak, Fiserv, TD Canada Trust, TD, Consumer, Thompson, Dun & Bradstreet, Federal Housing Finance Agency, Management

MCLEAN, Va., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Lance Drummond will become chair of Freddie Mac’s Board of Directors, the company announced today.

Key Points: 
  • MCLEAN, Va., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Lance Drummond will become chair of Freddie Mac’s Board of Directors, the company announced today.
  • The company is fortunate to have exceptional leaders, such as Sara Mathew and Lance Drummond, overseeing that effort,” said Sandra Thompson, Director of the Federal Housing Finance Agency.
  • Drummond joined the Freddie Mac Board in 2015, and currently serves as Chair of the Board’s Compensation and Human Capital Committee.
  • Thompson continued, “On behalf of FHFA, I wish to express my deep appreciation to Sara Mathew for her decade of service to Freddie Mac.

Intuitive Appoints Sreelakshmi Kolli to its Board of Directors

Retrieved on: 
Tuesday, October 31, 2023
Woman, American City Business Journals, Silicon, Innovation, Parliamentary Information Technology Committee, Engineering, Align Technology, Malaviya National Institute of Technology, Jaipur, Transformation, Trustee, Zimmer, Regulation, University, Information technology, Accenture, Digital platform, Audit committee, Management, Audit, Kolli

She joined the company in 2003 and held positions of increasing responsibility, leading and transforming business operations and engineering platforms.

Key Points: 
  • She joined the company in 2003 and held positions of increasing responsibility, leading and transforming business operations and engineering platforms.
  • Kolli is on the board of directors for Zimmer Biomet, serves as chair of Zimmer Biomet’s Quality, Regulatory & Technology Committee and is a member of its Audit Committee.
  • She has served as an external advisor on the Board of Trustees Committee on Information Technology at the University of San Francisco.
  • With Kolli’s addition, and as part of Intuitive’s ongoing board balancing and succession plan, the board of directors will expand to 12 members.

Baxter Announces Updates to Its Board of Directors

Retrieved on: 
Monday, August 21, 2023
Medical Devices, Health, Health Technology, General Health, Pharmaceutical, Biotechnology, Baxter, Baxter International, In re Caremark International Inc. Derivative Litigation, Envelope (music), Growth, Quest Diagnostics, NYSE, Parliamentary Information Technology Committee, Management

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed Stephen (Steve) H. Rusckowski, former chairman, president and chief executive officer of Quest Diagnostics, Inc., to its board of directors.

Key Points: 
  • Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed Stephen (Steve) H. Rusckowski, former chairman, president and chief executive officer of Quest Diagnostics, Inc., to its board of directors.
  • In addition, the company has announced that Michael (Mike) Mahoney will be resigning from the board effective Sept. 13, 2023, following nearly eight years of service.
  • “We are pleased to welcome Steve to Baxter’s board,” said José (Joe) E. Almeida, chairman, president and chief executive officer.
  • “His exemplary operational expertise, track record as a transformational leader, and distinguished career as a strategic operational executive will enhance our current board membership.

Cabaletta Bio Reports Second Quarter 2023 Financial Results and Provides Business Update

Retrieved on: 
Thursday, August 10, 2023
Exercise, Science, Gilead Sciences, Lupus, Maintenance, CD19, DM, MuSK protein, Gene, Compensation, Non-Hodgkin lymphoma, Immunoglobulin therapy, Clinical trial, Cyclophosphamide, Dermatomyositis, SLE, Syndrome, Pemphigus, Asis Datta, LN, Parliamentary Information Technology Committee, Myositis, Citigroup, Investigational New Drug, MG, Patient, Investment, Annual general meeting, Cell, American Society of Gene and Cell Therapy, Kite Pharma, Research, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, IND, Society, Conference, Food, MPV, Disease, Pharmaceutical industry, Vaccine, Cryptocurrency, Cabaletta

PHILADELPHIA, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today reported financial results for the second quarter ended June 30, 2023, and provided a business update.

Key Points: 
  • PHILADELPHIA, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today reported financial results for the second quarter ended June 30, 2023, and provided a business update.
  • Cabaletta anticipates generating 3-month clinical data on efficacy and tolerability in initial CABA-201 treated patients by the first half of 2024.
  • 2023 Cantor Global Healthcare Conference, which is being held from September 26-28, 2023 in New York, NY.
  • As of June 30, 2023, Cabaletta had cash, cash equivalents and short-term investments of $176.3 million, compared to $106.5 million as of December 31, 2022.

Cabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors

Retrieved on: 
Monday, July 24, 2023
Science, Gilead Sciences, University, Parliamentary Information Technology Committee, AbbVie, Hematology, Non-Hodgkin lymphoma, Genentech, Pharmacyclics, Marketing, Acquisition, Patient, Celgene, Autoimmune disease, National Directorate for Migration (Argentina), Kite Pharma, Professional Football Compensation Committee, Compensated emancipation, Murray State University, Pharmaceutical industry

PHILADELPHIA, July 24, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced the appointment of Shawn Tomasello to its Board of Directors. Ms. Tomasello has over 35 years of experience in the life sciences industry, including specific expertise in CD19-CAR T therapy, where she most recently served as the Chief Commercial Officer of Kite Pharma, Inc. between 2015 and 2018, leading the worldwide commercialization effort for the CD19-CAR T cell therapy, Yescarta®, and playing a key role in its acquisition by Gilead Sciences, Inc. As part of her appointment to the Board of Directors, Ms. Tomasello will become a member of the Compensation Committee and the newly formed Science & Technology Committee.

Key Points: 
  • PHILADELPHIA, July 24, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced the appointment of Shawn Tomasello to its Board of Directors.
  • “Shawn is a recognized biopharmaceutical leader with a proven track record building large-scale commercial organizations to bring transformative therapies to patients in need, including having overseen the global commercial launch of the leading approved CD19-CAR T cell therapy,” said Steven Nichtberger, M.D., Chief Executive Officer and Co-founder of Cabaletta.
  • Prior to joining Kite Pharma, she was the Chief Commercial Officer of Pharmacyclics LLC, now part of AbbVie Inc., where she led both commercial and medical affairs.
  • “I am excited to join Cabaletta’s Board of Directors and to support the company’s vision to develop and potentially launch the first targeted curative cell therapies for patients with autoimmune diseases,” said Shawn Tomasello.

Alison Rand Appointed to the Regions Financial Corp. and Regions Bank Boards of Directors

Retrieved on: 
Wednesday, July 19, 2023
Banking, Asset Management, Professional Services, Finance, Treasury, Alison, University, Parliamentary Information Technology Committee, Audit, Regions Financial Corporation, Audit committee, Business, Toronto Region Board of Trade, Multimedia, Strategic planning, Retirement, Investment, CFO, Knowledge, First Franklin Financial Corp., KPMG, Financial management, NYSE, RF, Management, Science, Region, Accounting, Primerica

Regions Financial Corp. (NYSE:RF) on Wednesday announced Alison Rand has been appointed to the boards of Regions Financial Corp. and its subsidiary, Regions Bank .

Key Points: 
  • Regions Financial Corp. (NYSE:RF) on Wednesday announced Alison Rand has been appointed to the boards of Regions Financial Corp. and its subsidiary, Regions Bank .
  • View the full release here: https://www.businesswire.com/news/home/20230719019754/en/
    Alison Rand has been appointed to the Regions Financial Corp. and Regions Bank Boards of Directors, effective Oct. 1, 2023.
  • (Photo: Business Wire)
    An experienced corporate executive, Rand has served as Executive Vice President and Chief Financial Officer for Primerica for 23 years.
  • “Alison’s depth of experience will complement the vision and focus of the Regions Boards of Directors as we develop and enhance strategies to support the company’s commitment to deliver consistent, sustainable long-term performance,” said Charles McCrary, Chair of the Regions Financial Corp. and Regions Bank Boards.

Walgreens Boots Alliance Appoints Tom Polen to Board of Directors

Retrieved on: 
Wednesday, July 12, 2023
Retail, Health, Consumer, Seniors, Specialty, General Health, Pharmaceutical, Informatics, Walgreens Boots Alliance, Parliamentary Information Technology Committee, U.S. Department of Defense Strategy for Operating in Cyberspace, Salisbury University, American Heart Association, Bard (company), BD (company), Innovation, Research, CareFusion, WBA, Committee, Becton, Dickinson and Company headquarters, Business administration, Discovery, Acquisition, Johns Hopkins University, Patient, Payment, AdvaMed, Growth, Becton, Stefano Pessina, Policy, Supply, Master of Business Administration, Medtech, Pharmaceutical industry, Management

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the appointment of Tom Polen to the company’s board of directors.

Key Points: 
  • Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the appointment of Tom Polen to the company’s board of directors.
  • Polen is the chairman, CEO and president of BD (Becton, Dickinson and Company), one of the world’s largest medical technology companies.
  • “I am pleased to welcome Tom to the WBA Board of Directors.
  • He joins at a pivotal time as we enter the next phase of our healthcare transformation,” said Roz Brewer, CEO, Walgreens Boots Alliance.

ZeroNox Announces Nomination of Colleen Birdnow Brown to Board of Directors of Combined Company upon Closing of Business Combination with Growth for Good

Retrieved on: 
Wednesday, July 12, 2023
Other Manufacturing, Alternative Vehicles, Fuels, EV, Electric Vehicles, Automotive, General Automotive, Engineering, Automotive Manufacturing, Manufacturing, Other Automotive, Good, Fisher Communications, Private sector, Partnership, CareerBuilder, Pacific Northwest, Big 5 Sporting Goods, Parliamentary Information Technology Committee, National Association of Corporate Directors, Public policy, Innovation, Aspen, Strategic planning, Port Blakely, Bainbridge Island, Washington, Organization, Acquisition, Classified Ventures, Carnegie Mellon University, Spark Networks, Corporation, NACD, Aspen Institute, National Association, TrueBlue, United Way, Management, American Apparel, Growth

Brown is expected to serve on the Board of Directors of the combined company.

Key Points: 
  • Brown is expected to serve on the Board of Directors of the combined company.
  • Ms. Brown brings extensive board leadership and executive experience in strategic planning, operations, finance and technology.
  • Ms. Brown was a former Director, President, and Chief Executive Officer of Fisher Communications, a public multimedia and technology company.
  • Completion of the transaction is subject to approval by Growth for Good’s shareholders and other customary closing conditions.